A cellular assay for spike/ACE2 fusion: quantification of fusion-inhibitory antibodies after COVID-19 and vaccination
F. Abdul, P. Ribaux, A. Caillon, A. Malezieux, V. Prendki, N. Zhukovsky, F. Delhaes, K.-H. Krause, O. Preynat-Seauve
This paper develops a cell-based assay to measure fusion-inhibitory antibodies against SARS-CoV-2 by detecting Spike/ACE2-dependent cell-to-cell fusion using split luciferase.
bioRxiv · Jun 9, 2022Microbiology